Xenitra (XEN) Stock Overview
Operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
XEN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Xenitra Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0025 |
| 52 Week High | AU$0.004 |
| 52 Week Low | AU$0.002 |
| Beta | 0.61 |
| 1 Month Change | -28.57% |
| 3 Month Change | 0% |
| 1 Year Change | -28.57% |
| 3 Year Change | -37.50% |
| 5 Year Change | -87.50% |
| Change since IPO | -98.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| XEN | AU Specialty Retail | AU Market | |
|---|---|---|---|
| 7D | -16.7% | 0.6% | -2.5% |
| 1Y | -28.6% | -40.6% | -2.9% |
Return vs Industry: XEN exceeded the Australian Specialty Retail industry which returned -40.6% over the past year.
Return vs Market: XEN underperformed the Australian Market which returned -2.9% over the past year.
Price Volatility
| XEN volatility | |
|---|---|
| XEN Average Weekly Movement | 36.8% |
| Specialty Retail Industry Average Movement | 6.3% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 3.8% |
Stable Share Price: XEN's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: XEN's weekly volatility (37%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | n/a | xenitra.com |
Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritional product trading. It sells its products through a network of B2B wholesale, retail distribution, and e-commerce platforms.
Xenitra Limited Fundamentals Summary
| XEN fundamental statistics | |
|---|---|
| Market cap | AU$10.70m |
| Earnings (TTM) | -AU$5.18m |
| Revenue (TTM) | AU$20.34m |
Is XEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XEN income statement (TTM) | |
|---|---|
| Revenue | AU$20.34m |
| Cost of Revenue | AU$20.74m |
| Gross Profit | -AU$403.00k |
| Other Expenses | AU$4.78m |
| Earnings | -AU$5.18m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | -1.98% |
| Net Profit Margin | -25.47% |
| Debt/Equity Ratio | 684.7% |
How did XEN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/17 21:00 |
| End of Day Share Price | 2026/09/16 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Xenitra Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.